Cargando…

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?

Neuroendocrine differentiation (NED) marks a structural and functional feature of certain cancers, including prostate cancer (PCa), whereby the malignant tissue contains a significant proportion of cells displaying neuronal, endocrine, or mixed features. NED cells produce, and can secrete, a cocktai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grigore, Alexandru Dan, Ben-Jacob, Eshel, Farach-Carson, Mary C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347593/ https://www.ncbi.nlm.nih.gov/pubmed/25785244 http://dx.doi.org/10.3389/fonc.2015.00037

Ejemplares similares

Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?
por: Farach-Carson, Mary C., et al.
Publicado: (2017)

The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)

Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
por: Hu, Chang-Deng, et al.
Publicado: (2015)

Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
por: Su, Ruopeng, et al.
Publicado: (2022)

Prostate tumor neuroendocrine differentiation via EMT: The road less traveled
por: Dicken, Haley, et al.
Publicado: (2019)

Tumor Budding: The Name is EMT. Partial EMT.
por: Grigore, Alexandru Dan, et al.
Publicado: (2016)

Endocrine and paracrine characteristics of neuroendocrine prostate cancer
por: Arman, Tarana, et al.
Publicado: (2022)

Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
por: Ando, Takashi, et al.
Publicado: (2020)

JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer
por: Pawar, Jogendra Singh, et al.
Publicado: (2023)

The Concept of Hormesis in Cancer Therapy – Is Less More?
por: Gaya, Andy, et al.
Publicado: (2015)

Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions
por: Ramezani, Saleh, et al.
Publicado: (2021)

Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2015)

Primary neuroendocrine prostate cancer with adrenal gland metastasis
por: Muñoz López, Antonio Yaromin, et al.
Publicado: (2021)

Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases
por: Zhang, Qingfu, et al.
Publicado: (2021)

Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation
por: Bergamini, Marco, et al.
Publicado: (2022)

A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells via an Ectopic Olfactory Receptor
por: Abaffy, Tatjana, et al.
Publicado: (2018)

Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
por: Wang, Zheng, et al.
Publicado: (2020)

A rare case of prostate neuroendocrine tumor: A case report
por: Teh, Shunxing, et al.
Publicado: (2022)

Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
por: Yoshida, Tsukasa, et al.
Publicado: (2022)

Neuroendocrine prostate cancer treated with multimodal examination and therapy: A case report
por: Hara, Midori, et al.
Publicado: (2022)

Grade G2 Rectal Neuroendocrine Tumor Is Much More Invasive Compared With G1 Tumor
por: Li, Yi-Wei, et al.
Publicado: (2021)

Editorial: Endocrine and Neuroendocrine Systems of Invertebrate Deuterostomes
por: Satake, Honoo, et al.
Publicado: (2019)

Co-occurrence of Dermatomyositis and Polycythemia Unveiling Rare de Novo Neuroendocrine Prostate Tumor
por: Papagoras, Charalampos, et al.
Publicado: (2018)

Hypercalcemia due to parathyroid hormone-related peptide secreted by neuroendocrine dedifferentiated prostate cancer
por: Ando, Takashi, et al.
Publicado: (2018)

A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
por: Gan, Yu, et al.
Publicado: (2023)

Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis
por: Liu, Bo, et al.
Publicado: (2021)

Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review
por: Cham, Jason, et al.
Publicado: (2021)

Gross Findings of Widespread Visceral Metastasis of Prostatic Adenocarcinoma With Neuroendocrine Features: A Case Report
por: Habibian, David J., et al.
Publicado: (2016)

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
por: Hakozaki, Yuji, et al.
Publicado: (2018)

Small cell carcinoma with neuroendocrine differentiation of subglottic larynx- a case report
por: Becht, Rafał, et al.
Publicado: (2023)

Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
por: Nouri, Mannan, et al.
Publicado: (2014)

Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network
por: Lee, Ahn R., et al.
Publicado: (2018)

Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors
por: Sigorski, Dawid, et al.
Publicado: (2021)

High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer
por: Chen, Lei, et al.
Publicado: (2023)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)

Transurethral resection and surveillance of a well-differentiated neuroendocrine tumor in a ileal neobladder
por: Kang, Audry, et al.
Publicado: (2020)

When less is more: non-monotonic spike processing in neurons
por: Arnoldt, Hinrich, et al.
Publicado: (2013)

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers
por: Soundararajan, Rama, et al.
Publicado: (2018)

TPX2 Enhanced the Activation of the HGF/ETS-1 Pathway and Increased the Invasion of Endocrine-Independent Prostate Carcinoma Cells
por: Zhou, Hongqing, et al.
Publicado: (2021)

Less is more
por: Alayón, R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q6pn7cfgrg3vk8m3a8oqu5ebpd